Australia Markets closed

WELL Health Technologies Corp. (WHTCF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
3.5043+0.0203 (+0.58%)
At close: 03:56PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close3.4840
Open3.1000
BidN/A x N/A
AskN/A x N/A
Day's range3.1000 - 3.5300
52-week range1.8858 - 4.5000
Volume10,979
Avg. volume17,953
Market cap799.569M
Beta (5Y monthly)1.39
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date09 May 2023 - 15 May 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    WELL Health Reports Record Revenue Results for Q4 and Full Year 2022 and Provides Strong Growth Outlook for 2023

    WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce its audited consolidated financial results for the fiscal year and fourth quarter ended December 31, 2022.

  • PR Newswire

    WELL Health to Announce Fourth Quarter and Year End 2022 Financial Results on March 21, 2023

    WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce the Company will release its Fiscal Fourth Quarter and Year End 2022 financial results for the period ended December 30, 2022, on Tuesday, March 21, 2023. The Company will hold a conference call and simultaneous webcast to discus

  • PR Newswire

    WELL Makes Investment in doctorly and Launches Strategic Alliance, to tech enable German Doctors

    WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (Frankfurt: W7V.F) ("WELL" or the "Company"), a company focused on positively impacting health outcomes by leveraging technology to empower healthcare providers and their patients globally, is pleased to announce it has made a strategic investment, through its wholly owned subsidiary, WELL Ventures, in doctorly GmbH ("doctorly"), a medical practice management software provider based in Germany. WELL Ventures is investing as part of a synd